Articles By Ed Miseta

31. Technology Advancements Spur Adoption Of Virtual Trials 11/27/2019

    Virtual trials have been around for years, so why are they still met with skepticism? Clinical trial executives from Janssen and Astellas weigh in on this hot topic for 2020.

32. Patient Diversity Starts With Community Connections 8/30/2019

    When it comes to clinical trials, the pharmaceutical industry still has a patient diversity problem. The face of patients in clinical trials is not representative of the face of America.

33. Success In HIV Treatments Creates Additional Challenges For Drug Developers 7/1/2019

    HIV drug developers have a whole new set of challenges, including making the regimens simpler better tolerated. In addition, since today’s patients can access these medicines through pharmacies, they no longer have the incentive to take part in clinical studies.

34. Regeneron Manages Clinical Costs In A Fast-Growing Organization 5/1/2019

    Bari Kowal, VP and head of global clinical operations at Regeneron, says sponsors and CROs must partner to make clinical trial execution more efficient and cost-effective.

35. CRO Leadership Awards Move To Primetime 5/1/2019

    If you are looking for a CRO to help take your molecule through clinical trials and the process of gaining regulatory approval, who do you turn to? It’ not like there is an Angie’s List for CROs.

36. AbbVie Goes All-In On Wearables And Digital Technologies 5/1/2019

    Three years ago, AbbVie decided to stop talking about using digital technologies in clinical trials and start actually using them. The company then began deploying wearables in three clinical trials.

37. Master Trial Protocols: Better For Pharma, Better For Sites 2/1/2019

    The primary benefit of master trial protocols for drug companies is the ability to concurrently evaluate multiple studies that may have different objectives, saving both time and money.

38. Oncology Studies Show Pharma The Future Of Clinical Trials 12/3/2018

    What does the future hold for oncology trials, which now comprise around 80 percent of all clinical research? We spoke to three experts who shared their insights into where the industry is headed in 2019 and beyond.

39. A Small Biotech Takes On Some Big Clinical Trial Challenges 11/7/2018

    Evofem Biosciences is on the cusp of releasing a revolutionary birth control product. But before the FDA gives its approval, this small biopharma has to navigate two very different clinical trials.

40. Novartis Turns To Digital Technologies For Clinical Trials 9/3/2018

    Jake LaPorte, head of digital development for Novartis, talks about how AI, IoT, and machine learning are all being leveraged for better clinical trials.